Electromed Stock Today

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:4em;padding-top: 25px;;'>EL</div>


7 / 100

Odds of Distress

Equity ratings for Electromed are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting December 30, 2019 and ending today March 29, 2020. Click here to learn more.

Electromed Profile

Next fiscal quarter end is expected on March 31, 2020. Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company was founded in 1992 and is headquartered in New Prague, Minnesota. Electromed operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 119 people. more on Electromed
Electromed Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Electromed SEC Filings
Electromed SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameElectromed
CEO and President and DirectorKathleen SkarvanView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Average Analyst Recommendation
Piotroski F Score
Academic score to determine the current strength of Electromed financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Electromed ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Few selected profitability drivers of Electromed representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Gross Margin
Profit Margin
Electromed (ELMD) is traded on BATS Exchange in USA. It is located in 500 Sixth Avenue NW and employs 119 people. Electromed is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 79.44 M. Electromed conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 8.48 M outstanding shares of which 20.28 K shares are currently shorted by private and institutional investors with about 0.14 trading days to cover. Electromed currently holds about 9.21 M in cash with 3.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09.
Check Electromed Probability Of Bankruptcy

Ownership Allocation (%)

Electromed Stock Price Odds Analysis

Odds Down 12.03HorizonTargetOdds Up 12.03
92.98%30 days
Based on normal probability distribution, the odds of Electromed to move above current price in 30 days from now is about 6.98 (This Electromed probability density function shows the probability of Electromed Stock to fall within a particular range of prices over 30 days) .

Electromed Stock Top Holders

Electromed Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Tocqueville Asset Management LpCommon Shares432 K3.7 M
Vanguard Group IncCommon Shares286.6 K2.5 M
View Electromed Diagnostics

Electromed Income Statement Over Time

Electromed Income Statement is one of the three primary financial statements used for reporting Electromed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Electromed revenue and expense. Electromed Income Statement primarily focuses on the company's revenues and expenses during a particular period. Electromed Interest Expense is expected to significantly decrease based on the last few years of reporting. The last year's Interest Expense was at 44,880.3. The current year Net Income is expected to grow to about 3.6 M, whereas Earning Before Interest and Taxes EBIT is expected to decline to about 2.7 M. View More Fundamentals
Consolidated Income    Earning Before Interest and Taxes EBIT    Earning Before Interest and Taxes USD    

Electromed Stock Against Markets

Did you try this?

Run Price Transformation Now


Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Module

Electromed Upcoming and Recent Events

Electromed Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportMay 5, 2020
Next Earnings ReportAugust 25, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndAugust 25, 2020
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Electromed Corporate Filings

Electromed SEC Reporting

Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Regulation FD Disclosure

Electromed Corporate Directors

Thomas Hagedorn Independent Director
Stan Erickson Independent Director
William Eckles Independent Director
Continue to Investing Opportunities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page